These results reveal that the TNF/TNFR member family may exert specific effects on the formation of the tumor immune microenvironment in DLBCL through distinct ligand-receptor combinations, thereby impacting tumor development and the prognosis of DLBCL patients. The gene discussed is TNF; the disease is diffuse large B-cell lymphoma.